- metelimumab
-
A human monoclonal antibody intended for the treatment of scleroderma but later dropped in favour of alternatives.
Wikipedia foundation.
Wikipedia foundation.
Metelimumab — ? Monoclonal antibody Type Whole antibody Source Human Target TGF beta 1 Clinical data Pregnancy cat. ? Legal status … Wikipedia
Daclizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target CD25 Clinical data Trade names Zenapax AHFS/Drugs.com … Wikipedia
Omalizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target IgE Fc region … Wikipedia
Natalizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target alpha 4 integrin Clinical data Trade names Tysabri AHFS/ … Wikipedia
Odulimomab — ? Monoclonal antibody Type Whole antibody Source Mouse Target CD11a Clinical data Pregnancy cat. ? Legal status … Wikipedia
Maslimomab — ? Monoclonal antibody Source Mouse Target T cell receptor Clinical data Pregnancy cat. ? Legal status ? … Wikipedia
Visilizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target CD3 receptor Clinical data Pregnancy cat. ? Legal status … Wikipedia
Mepolizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target IL 5 Clinical data Pregnancy cat. ? Legal status … Wikipedia
Nerelimomab — ? Monoclonal antibody Type Whole antibody Source Mouse Target TNF alpha Clinical data Pregnancy cat. ? Legal status ? … Wikipedia
Morolimumab — ? Monoclonal antibody Type Whole antibody Source Human Target RhD Clinical data Pregnancy cat. ? Legal status … Wikipedia